Flagship Pioneering Unveils Microbiome Focused Kintai Therapeutics

Flagship Pioneering Unveils Microbiome Focused Kintai Therapeutics

Source: 
CP Wire
snippet: 

 On 4/16/19, Flagship Pioneering,  unveiled Kintai Therapeutics and named Paul-Peter Tak, M.D., Ph.D., as president, chief executive officer, and member of the board of directors. Kintai is focused on leveraging the body's diverse signaling networks to pioneer a new class of Precision Enteric Medicine™ therapeutics that restore health and fight disease.